Sensitive matrix gel diffusion test for the detection of Australia antigen

Area of Science:

• Immunology
• Virology
• Diagnostic Assays

Background:

• Australia antigen (Hepatitis B surface antigen) is a key marker for Hepatitis B virus infection.
• Accurate and sensitive detection methods are crucial for diagnosing and managing Hepatitis B.
• The complement fixation test (CF) is a recognized but potentially complex method for antigen detection.

Purpose of the Study:

• To develop and evaluate a novel matrix gel diffusion (MGD) procedure for Australia antigen detection.
• To compare the sensitivity and performance of the MGD test against the established complement fixation (CF) test.

Main Methods:

• A matrix gel diffusion (MGD) assay was developed using a thin agar layer (0.1 mm) with an integrated plastic matrix.
• Serum samples were introduced directly onto the agar surface via wells in the plastic matrix.
• The MGD test performance was evaluated using a panel of 11 sera, comparing results with the complement fixation test (CF).

Main Results:

• The developed MGD procedure demonstrated sensitivity comparable to the complement fixation test (CF).
• Endpoint titers for antigen detection in 11 sera ranged from 1:8 to 1:512 using CF.
• MGD test results for antigen detection were within one dilution of the CF test endpoints, indicating high agreement.

Conclusions:

• The matrix gel diffusion (MGD) test is a sensitive and reliable method for detecting Australia antigen in serum.
• MGD offers a viable alternative to the complement fixation test (CF) with comparable performance.
• This assay provides a valuable tool for Hepatitis B diagnosis and epidemiological studies.